The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease

Hippokratia

Volumn 13, Issue 3, 2009, Pages 161-164

  Idrizi, Alma ^a,c   Barbullushi, M ^a   Petrela, E ^b   Kodra, S ^a   Koroshi, A ^a   Thereska, N ^a  

^a Service of Nephrology   (Albania)

^b UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^c NONE   (Albania)

Author keywords

Autosomal dominant polycystic kidney disease; Gross hematuria; Renal stone; Urinary tract infection

Indexed keywords

CALCIUM OXALATE; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; NALIDIXIC ACID; URATE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CALCULATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HEMATURIA; HUMAN; KAPLAN MEIER METHOD; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROLITHIASIS; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; RISK; SURVIVAL RATE; SURVIVAL TIME; URINARY TRACT INFECTION;

EID: 68049139580     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Simon HB, Thompson GJ. Congenital renal polycystic disease. JAMA. 1955; 159: 657-662.
2. Milutinovic J, Fialkow PJ, Agodoa LY, et al. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med. 1984; 212: 511-522. (Pubitemid 15209483)
3. Delaney VB, Adler S, Bruns FJ, et al. Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis. 1985; 5: 104-111. (Pubitemid 15171817)
4. Torres WE, Wilson DM, Hattery RR, Segura JW. Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993; 22: 513-519. (Pubitemid 23308959)
5. Levine E, Grantham JJ. Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. Am J Roentgenol. 1992; 159: 77-81.
6. Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty four patients and their families. Acta Med Scand .1957; 328: 255-256.
7. Segal AJ, Spataro RF, Barbaric ZL. Adult polycystic kidney disease: a review of 100 cases. J Urol. 1967; 118: 711-713.
8. Torres WE, Erickson SB, Smith LH, Wilson DM, et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988; 11: 318-325. (Pubitemid 18203458)
9. Gabow PA, Kaenny WB, Johnson AM, et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int. 1989; 35: 675-680. (Pubitemid 19051769)
10. Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987; 82: 714-718. (Pubitemid 18138559)
11. Chapman AC, Thickman D, Gabow PA. Percutaneous cysts puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1990; 16: 252-255. (Pubitemid 20342444)
12. Pirson Y, Grunfeld JP. Autosomal dominant polycystic kidney disease. In Cameron JS, Davison Am, Grunfeld JP, Kerr DNS, Ritz E, eds. Oxford: Oxford University Press. 1992; 2171-2188.
13. Gabow PA, Johnson AM, Kaenny WB, et al. Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int. 1992; 41: 1311-1319.
14. Kaehny WD, Gabow PA. Polycystic kidney disease: Clinical, radiologic and genetic approaches to problems in diagnosis, in Narins RG (ed): Contemporary Issues in Nephrology: Diagnostic Techniques in Renal Disease. New York, NY, Churchill Livingstone 1992; 47-72.
15. Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1992; 20: 140-143.
16. Milutinovic J, Fialkow PJ, Agodoa LY, et al. Clinical manifestations of autosomal polycystic kidney disease in patients older than 50 years. Am J Kidney Dis. 1990; 15: 237-243. (Pubitemid 20151184)
17. Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol. 2009; 4: 838-844.
18. Grampsas SA, Chandhoke PS, Fan J, et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000; 36: 53-57. (Pubitemid 30432564)
19. Cheidde L, Ajzen SA, Tamer Langen CH, Christophalo D, Heilberg IP. A critical appraisal of the radiological evaluation of nephrocalcinosis. Nephron Clin Pract. 2007; 106: 119-124. (Pubitemid 47016330)
20. Gibson P, Watson ML. Cyst infection in polycystic kidney disease: a clinical challenge. Neph Dial Transplant. 1998;13: 2455-2457. (Pubitemid 28445847)
21. Rule AD, Torres VE, Chapman AB, et al. CRISP Consortium Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort. J Am Soc Nephrol. 2006; 17: 854-862.
22. Bennett WM, Elzinga LW, Pulliam JP, Rashad AL, and Barry JM. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 1985; 6: 400-404. (Pubitemid 16172678)
23. Bennett WM, Elzinga LW. Clinical management of autosomal dominant polycystic kidney disease. Kidney Int. 1993; 44: (Suppl 42): S74-S79.
24. Anderson GA, Degroot D, Lawson K. Polycystic Renal Disease. Urology. 1993; 2: 358-364.